Amberpharmsp. z o.o.

Manufacture of other food products not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-03-15
Share capital
5 000,00 PLN
Activity description

Amberpharm is a specialist in dietary supplements and cosmetics designed for sensitive and allergy-prone skin. The company manufactures a wide range of products, including vitamins, probiotics, and specialized cosmetics for various skin types, while also offering comprehensive contract manufacturing services that cover all stages from product development to market entry.

Registered address
ul. Szafarnia 11/F8, 80-755 Gdańsk, Poland
Website
amberpharm.euWebsite active
Email
Email warning
Phone

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 300.04kMedianUSD 266.29kAverageUSD 5.03m
Net profit
This companyUSD -59.93kMedianUSD 2.47kAverageUSD 348.58k
Operating costs
This companyUSD 350.27kMedianUSD 259.61kAverageUSD 4.45m
Assets
This companyUSD 147.00kMedianUSD 249.77kAverageUSD 3.86m

Bank accounts

Registered as a VAT taxpayer on 2020-02-14. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Ewa Brożek Cantillana — Attorney-in-fact (sole)
Sergio Cantillana Valencia — President of the Management Board

Manner of representation

President of the Management Board independently, or two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy

Ownership

OwnerSharesShare valueStake
Sergio Esteban Cantillana Valencia (54)
100$1,350.62100%

Beneficial owners

Person
Ewa Elżbieta Brożek-Cantillana (50)
Sergio Esteban Cantillana Valencia (54)

Competitors

Name
IOCsp. z o.o.
Bonafarmsp. z o.o.
Pharmavenesp. z o.o.
Labs212sp. z o.o.
Colostrum Polskasp. z o.o.
Vetamedsp. z o.o.
BiofusionS.A.
Sygmesp. z o.o.
Green Worldsp. z o.o.
Fuelup Factorysp. z o.o.

Change history

DateEvent
2024-01-29PKD change
2020-02-19Address change
2019-09-18Address change
2019-03-15Entered in the register

FAQ

Last updated: 2026-04-11